IL107255A - Chewable preparations containing ranitidine - Google Patents

Chewable preparations containing ranitidine

Info

Publication number
IL107255A
IL107255A IL10725593A IL10725593A IL107255A IL 107255 A IL107255 A IL 107255A IL 10725593 A IL10725593 A IL 10725593A IL 10725593 A IL10725593 A IL 10725593A IL 107255 A IL107255 A IL 107255A
Authority
IL
Israel
Prior art keywords
ranitidine
chewable
tablet
flavouring
physiologically acceptable
Prior art date
Application number
IL10725593A
Other languages
English (en)
Hebrew (he)
Other versions
IL107255A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL107255A0 publication Critical patent/IL107255A0/xx
Publication of IL107255A publication Critical patent/IL107255A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL10725593A 1992-10-13 1993-10-12 Chewable preparations containing ranitidine IL107255A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221414A GB9221414D0 (en) 1992-10-13 1992-10-13 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL107255A0 IL107255A0 (en) 1994-01-25
IL107255A true IL107255A (en) 1998-07-15

Family

ID=10723323

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10725593A IL107255A (en) 1992-10-13 1993-10-12 Chewable preparations containing ranitidine

Country Status (25)

Country Link
US (1) US5593685A (cs)
EP (2) EP0664697B1 (cs)
JP (1) JP2918691B2 (cs)
KR (1) KR950703327A (cs)
AT (1) ATE166572T1 (cs)
AU (1) AU676690B2 (cs)
BG (1) BG99567A (cs)
CA (1) CA2147000A1 (cs)
CZ (1) CZ94495A3 (cs)
DE (1) DE69318844T2 (cs)
ES (1) ES2117718T3 (cs)
GB (1) GB9221414D0 (cs)
HU (2) HUT72497A (cs)
IL (1) IL107255A (cs)
MX (1) MX9306333A (cs)
NO (1) NO951432L (cs)
NZ (1) NZ256681A (cs)
OA (1) OA10144A (cs)
PH (1) PH31433A (cs)
PL (1) PL174359B1 (cs)
SG (1) SG49850A1 (cs)
SK (1) SK48395A3 (cs)
TW (1) TW271405B (cs)
WO (1) WO1994008560A1 (cs)
ZA (1) ZA937544B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU7468096A (en) * 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE19639343C2 (de) * 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
GB9715423D0 (en) 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
US6086920A (en) * 1998-08-12 2000-07-11 Fuisz Technologies Ltd. Disintegratable microspheres
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6491540B1 (en) * 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
DE69211688T2 (de) * 1991-04-04 1997-02-06 Procter & Gamble Kaubare antacida
BR9205827A (pt) * 1991-04-04 1994-06-28 Procter & Gamble Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
NO951432D0 (no) 1995-04-12
JP2918691B2 (ja) 1999-07-12
SK48395A3 (en) 1995-11-08
IL107255A0 (en) 1994-01-25
JPH08502272A (ja) 1996-03-12
US5593685A (en) 1997-01-14
MX9306333A (es) 1995-01-31
TW271405B (cs) 1996-03-01
SG49850A1 (en) 1998-06-15
EP0664697B1 (en) 1998-05-27
ES2117718T3 (es) 1998-08-16
BG99567A (en) 1995-12-29
EP0788789A1 (en) 1997-08-13
NO951432L (no) 1995-05-12
NZ256681A (en) 1997-10-24
ZA937544B (en) 1994-04-21
HUT72497A (en) 1996-05-28
PH31433A (en) 1998-11-03
AU676690B2 (en) 1997-03-20
GB9221414D0 (en) 1992-11-25
EP0664697A1 (en) 1995-08-02
WO1994008560A1 (en) 1994-04-28
DE69318844T2 (de) 1998-10-15
AU5143493A (en) 1994-05-09
HU211847A9 (en) 1995-12-28
HU9501053D0 (en) 1995-06-28
ATE166572T1 (de) 1998-06-15
DE69318844D1 (de) 1998-07-02
CZ94495A3 (en) 1995-10-18
CA2147000A1 (en) 1994-04-28
PL308356A1 (en) 1995-07-24
PL174359B1 (pl) 1998-07-31
OA10144A (en) 1996-12-18
KR950703327A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
AU676690B2 (en) Ranitidine chewable tablets
US5102665A (en) Pharmaceutical compositions
JPH02111719A (ja) 薬物吸着質
JP3587869B2 (ja) 医薬組成物
WO1996008238A1 (en) Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
AU677108B2 (en) Ranitidine and calcium carbonate pharmaceutical combination product
KR960011773B1 (ko) 궤양의 예방 및 치료용 의약 조성물
AU690664B2 (en) Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
CA2295037A1 (en) Aqueous compositions comprising ranitidine and lcmt sucrose
JPS62174020A (ja) 急性胃炎治療剤
KR20000048829A (ko) 액체 알렌드로네이트 제형

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void